Alex
At Best Startup Canada we track over 100,000 Canadian startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top British Columbia based Director operating in the Pharmaceutical space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.ca.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Andreas von Flotow
Director of Aurin Biotech
Dr. Andreas von Flotow is a successful serial technology entrepreneur, with interests ranging from aerospace to agriculture. He is also an accomplished researcher and inventor. Dr. von Flotow earned a PhD in aerospace engineering from Stanford University and joined the faculty of MIT where he taught and conducted research in spacecraft control and dynamics from 1985 to 1992. He then moved to the Columbia Gorge with his family and founded Hood Technology Corporation and other companies. Dr. von Flotow was the founding chairman of Insitu Inc., a pioneer in unmanned aircraft systems, which was acquired by Boeing in 2008 for a reported $400M. He is author and co-author of over 100 technical papers in refereed journals and conferences, and is the holder of over 25 patents. During his academic career, he supervised 7 PhD and 20 MS students. He currently serves as the President and Chairman of Hood Technology and is involved in numerous other business and investment interests.
Follow Andreas von Flotow:
About Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Hagen Kennecke
Director of Aurin Biotech
Dr. Hagen Kennecke is the Professional Practice Leader of Medical Oncology at the BC Cancer Agency Vancouver Centre, and is also an Associate Professor at the University of British Columbia (UBC). He received his MD from Dalhousie University in 1997 and subsequently did residency training in internal medicine and oncology. He is a fellow of the Royal College of Physicians of Canada and an executive member of the National Cancer Institute of Canada CTG GI Site Committee, and a member of the US Neuroendocrine and Rectal Tumor Task Force of the NCI GI Steering Committee. He is a strong advocate of patients with gastrointestinal cancers and has worked to improve education, treatment and outcomes for those affected by the disease. He founded the BCCA Colorectal Cancer Outcomes Unit and BCCA Colorectal Cancer Awareness Day. He is the author of 52 peer reviewed scientific articles as well as numerous invited presentations. He is passionate about finding new therapeutics for cancers and is currently conducting vital research into new therapy options for colorectal cancer patients. Dr. Kennecke has extensive experience in developing and conducting clinical trials with new therapeutic agents and brings this important expertise to the Board.
Follow Hagen Kennecke:
About Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Douglas Bell
Director of Aurin Biotech
Dr. Douglas Bell is a retired physician who received his MD from McGill University in 1955. After several years of general practice he entered post-graduate training in head and neck surgery. In 1975 he became a fellow of the Royal College of Surgeons in Canada (FRCS), the American College of Surgeons (ACS), and the American Academy of Otolaryngology–Head and Neck Surgery (AAOHNS). He was offered a position in the Head and Neck Surgery Department of the Scripps Clinic & Research facility in La Jolla, California. He was also appointed Assistant Clinical Professor at the University Hospital and the Veteran’s Hospital at the University of San Diego where he taught medical students and residents. Following lithotripsy treatment for a kidney stone at age 58 he developed a severe autoimmune disease which devastated him physically and ended his medical career. As a result he became extremely interested in researching autoimmune disorders. After reading journal articles regarding low molecular weight aurintricarboxylic acid synthetic complex he concluded it might be effective for him. He synthesized his own material and, after self-treatment, he and his family were ecstatic with the response. It provided him with the first positive relief from the overwhelming muscular fatigue he had endured for the previous 26 years.
Follow Douglas Bell:
About Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Edith G. McGeer
Foounder,Vice President & Director of Aurin Biotech
Dr. Edith McGeer is a professor emerita in the Faculty of Medicine at University of British Columbia (UBC). She is the former director of the Kinsmen Laboratory of Neurological Research at UBC. She received her BA from Swarthmore College and her PhD in chemistry from the University of Virginia at the age of 22. She worked for the DuPont Company in Wilmington, Delaware, winning three patents and a citation from the Delaware section of the American Chemical Society before moving with her husband to UBC’s medical school. She has served on the editorial boards of 15 international journals in the neuroscience field. She has recently been on numerous scientific review boards, particularly for the National Institutes of Health (NIH) in the United States, and was one of the initial members of the Executive Committee of the World Federation of Neurology Group on the Dementias. She is an Officer of the Order of Canada, a Fellow of the Royal Society of Canada, a member of the Order of British Columbia and the recipient of three honorary degrees. She is the author of 525 scientific articles, 10 patents, an author of the textbook Molecular Neurobiology of the Mammalian Brain with her husband Dr. Patrick McGeer and Sir John Eccles. The McGeers were both original members of the Highly Cited Researchers database of the ISI, being among the world’ top 100 most highly cited neuroscientists.
Follow Edith G. McGeer:
About Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Wade Attwood
President, Founder & Director of Green Mountain
Mr. Wade Attwood is President, co-founder and Director of GMHA. He is also a founder and director of General Harmonics, a private technology company. Prior to joining General Harmonics, Mr. Attwood worked as a Senior Advisor and Broker in the finance industry for 24 years at Canaccord Capital Corp. and Merrill Lynch Canada and its predecessors. Mr. Attwood has over 30 years of business experience and a history of successful ventures in public equity markets, private and public venture capital funding, initial public offerings, and corporate guidance and restructuring.
Follow Wade Attwood:
About Green Mountain: Green Mountain is an innovator in the field of cannabis pharmaceutical and wellness products.
GIPHY App Key not set. Please check settings